TMO

AI Research

Q4 2025 EPS $6.57 beat + dividend raised to $0.47 → Moderate Buy consensus

Thermo Fisher Scientific reported Q4 2025 EPS of $6.57, beating the $6.45 consensus by $0.12, with revenue of $12.22 billion exceeding analyst estimates of $11.95 billion. The company raised its quarterly dividend to $0.47 per share from $0.43, payable April 15 to shareholders of record March 13. The stock trades at approximately $471 with a consensus Moderate Buy rating and an average price target of $633.68, suggesting significant upside; institutional investors including Holocene Advisors and Lincluden Management have been increasing positions.